Part 3: Managing testing efficiencies – How to optimise next generation sequencing and HRR testing
Dr Alberto Bardelli talks to ecancer at the 14th Education Workshop on Molecular Targeted Therapy of Cancer(MTTC) conference in Sorrento, Italy about the use of less invasive 'blood biopsies' for the detection of tumour cells
For more video interviews from this meeting and other educational resources visit Serono Symposia International Foundation.
Part 3: Managing testing efficiencies – How to optimise next generation sequencing and HRR testing
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
Social determinants and survival outcomes in early-onset colorectal cancer in the US
The added value of integrative medicine
Insights into germline genetic screening of breast cancer patients
New classification for identifying HR myeloma based on cytogenetic abnormalities
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Multiple myeloma In Rwanda: The need for further research
GIST tumours and soft tissue sarcomas